Reproductive endocrine
Conditions
Interventions
Group A :doxycycline 100 mg Bid + metronidazole 400 mg Bid + cefdinir 100 mg tid for 14 days
Group B:doxycycline 100 mg Bid + metronidazole 400 mg Bid + cefdinir 100 mg tid + vitamin E 500 mg Bid + vitamin C 500 mg Bid for 14 days
Sponsors
People's Hospital of Guangxi Zhuang Autonomous Region
Eligibility
Sex/Gender
Female
Age
23 Years to 42 Years
Inclusion criteria
Inclusion criteria: 1. Transplantation cycle =2; 2. Patients with endometritis
Exclusion criteria
Exclusion criteria: Patients with a scarred uterus, endometrial polyps, intrauterine adhesions, uterine malformation, adenomyosis, endometriosis, severe inflammatory tubal effusion or severe heart, liver or kidney disease were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| live birth rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| ongoing pregnancy rate;positive hCG rate;implantation rate;early miscarriage rate;clinical pregnancy rate; | — |
Countries
China
Contacts
Public ContactQin Jinchun
People's Hospital of Guangxi Zhuang Autonomous Region
Outcome results
None listed